Firefly Neuroscience, INC DEF 14A proxy statements

Firefly Neuroscience, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for August 5, 2026, to address key corporate matters including director elections, auditor ratification, executive compensation, and amendments to incentive plans and the company's charter.

Firefly Neuroscience, Inc. filed an amendment to its definitive proxy statement, revising Proposal 4 to seek approval for a fixed increase in authorized shares from 101 million to 5.001 billion.

Firefly Neuroscience, Inc. will hold its Annual Meeting on October 27, 2025, seeking stockholder approval for director elections, auditor ratification, and significant increases in its equity incentive plan and total authorized shares.

Firefly Neuroscience is requesting shareholder approval to issue more than 20% of its common stock to two entities, Helena Special Opportunities LLC and Arena Business Solutions Global SPC II, Ltd, to comply with Nasdaq listing rules and secure necessary financing.

Firefly Neuroscience will hold its 2024 annual meeting of stockholders virtually on December 27, 2024, to vote on the election of directors, ratification of auditors, and executive compensation matters.